Ascendis Pharma A/S (NASDAQ:ASND) Price Target and Market Performance
Ascendis Pharma(US:ASND) Financial Modeling Prep·2026-03-06 05:02Jefferies sets a price target of $262 for NASDAQ:ASND, indicating a potential upside of approximately 10.39%.The company's participation in the TD Cowen 46th Annual Health Care Conference highlights its growth prospects.ASND's current trading price is $237.35, with a year's trading range between $124.06 and $248.60, showcasing volatility.Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company focused on developing therapies for rare diseases. The company is known for its innovative TransCon technol ...